Trilipix CV Outcomes Study To Focus On Patients With High Triglycerides, Low HDL-Cholesterol
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA follows its advisory committee’s recommendation and requires a post-marketing study of Abbott’s fibrate to determine whether combination use with a statin provides a cardiovascular benefit over statin monotherapy in high-risk patients.